Cereblon binding compounds, compositions thereof, and methods of treatment therewith
US-2025188056-A1 · Jun 12, 2025 · US
This page is not indexed by search engines while we improve data quality.
Tehrani Lida patents
Tehrani Lida is listed as an inventor on 25 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Tehrani Lida |
| Total patents | 25 |
| First publication | Feb 19, 2015 |
| Latest publication | Jun 12, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Cereblon binding compounds, compositions thereof, and methods of treatment therewith
US-2025100995-A1 · Mar 27, 2025 · US
Cereblon binding compounds, compositions thereof, and methods of treatment therewith
US-12227490-B2 · Feb 18, 2025 · US
Cereblon binding compounds, compositions thereof, and methods of treatment therewith
US-2024374591-A1 · Nov 14, 2024 · US
Cereblon binding compounds, compositions thereof, and methods of treatment therewith
US-2024368118-A1 · Nov 7, 2024 · US
Cereblon binding compounds, compositions thereof, and methods of treatment therewith
US-12103920-B2 · Oct 1, 2024 · US
Cereblon binding compounds, compositions thereof, and methods of treatment therewith
US-11739075-B2 · Aug 29, 2023 · US
Cereblon binding compounds, compositions thereof, and methods of treatment therewith
US-11634407-B2 · Apr 25, 2023 · US
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
US-2023119470-A1 · Apr 20, 2023 · US
Cereblon binding compounds, compositions thereof, and methods of treatment therewith
US-11560371-B2 · Jan 24, 2023 · US
Recent patents
Latest publications not already listed above.
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
US-11292796-B2 · Apr 5, 2022 · US
Cereblon binding compounds, compositions thereof, and methods of treatment therewith
US-2022002273-A1 · Jan 6, 2022 · US
Cereblon binding compounds, compositions thereof, and methods of treatment therewith
US-2021403454-A1 · Dec 30, 2021 · US
Cereblon binding compounds, compositions thereof, and methods of treatment therewith
US-2021403453-A1 · Dec 30, 2021 · US
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
US-2020262840-A1 · Aug 20, 2020 · US
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
US-10683298-B2 · Jun 16, 2020 · US
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
US-2019077806-A1 · Mar 14, 2019 · US
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
US-10167290-B2 · Jan 1, 2019 · US
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
US-2017342080-A1 · Nov 30, 2017 · US
Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
US-9795607-B2 · Oct 24, 2017 · US
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
US-9771371-B2 · Sep 26, 2017 · US
Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
US-9428509-B2 · Aug 30, 2016 · US
Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
US-9346812-B2 · May 24, 2016 · US
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
US-2016024101-A1 · Jan 28, 2016 · US
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
US-2015051397-A1 · Feb 19, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Signal Pharm Llc | 13 |
| Celgene Corp | 12 |
| Signal Pharmaceutical Llc | 3 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 25 |
| C07D487/04 | 13 |
| C07D471/04 | 13 |
| C07D401/14 | 12 |
| A61P29/00 | 10 |